NCT00436644 2014-04-16Lapatinib and Topotecan in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or CarboplatinMayo ClinicPhase 2 Completed18 enrolled 10 charts
NCT00447226 2012-06-12Randomized Discontinuation Study of Lapatinib Versus Placebo in Subjects With Documented Tumor Progression After Chemotherapy, or Where no Approved Therapy ExistsGlaxoSmithKlinePhase 2 Terminated32 enrolled 10 charts